首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial
【2h】

Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial

机译:精神分裂症患者对耐药性幻听的rTMS的临床反应的结构和功能性脑生物标志物:一项随机假手术双盲临床试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe potential of non-invasive repetitive transcranial magnetic stimulation (rTMS) to improve auditory verbal hallucinations (AVH) in schizophrenia patients has been increasingly explored over the past decade. Despite highly promising results, high inter-individual variability of clinical response and ineffective outcomes in a significant number of patients underscored the need to identify factors associated with the clinical response to rTMS. It should help improve the efficacy of rTMS in patients with medication-resistant AVH, and allow a better understanding of its neural impact. Here, we describe an exploratory study protocol which aims to identify structural and functional brain biomarkers associated with clinical response after an rTMS treatment for medication-resistant AVH in schizophrenia.
机译:背景技术过去十年来,越来越多地探索了非侵入性重复经颅磁刺激(rTMS)改善精神分裂症患者的听觉幻觉(AVH)的潜力。尽管取得了令人鼓舞的结果,但大量患者的临床反应之间存在很大的个体差异和无效的结果,这凸显了识别与rTMS的临床反应相关的因素的需要。它应该有助于提高rTMS在抗药性AVH患者中的疗效,并使其对神经的影响有更好的了解。在这里,我们描述了一项探索性研究协议,旨在确定精神分裂症患者抗药性AVH的rTMS治疗后与临床反应相关的结构和功能性脑生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号